AKT1 and neoplasm: Oral squamous CSC-derived small EVs transport the lncRNA UCA1 which, by sequestering miR-134, modulates the PI3K/AKT pathway via LAMC2 to drive macrophages toward an immunosuppressive M2 phenotype, thus promoting tumor growth and inhibiting T-cell function (158).